Directory

>

Patrick Au

avatar

Patrick Au

Vice President, Translational Research and Early Development | Ensoma

Boston, Massachusetts, United States

View contact details (it's free)

Patrick Au

Summary

Patrick Au is an accomplished Vice President specializing in Translational Research and Early Development within the biotechnology sector. With over 5 years of experience at the US FDA, he brings extensive knowledge in drug and biologics development across various therapeutic areas, including rare diseases and immuno-oncology. His expertise encompasses regulatory affairs, pharmacology, and toxicology, making him a key player in advancing innovative therapies. Patrick is a Diplomate of the American Board of Toxicology and holds a Regulatory Affairs Certification, highlighting his commitment to regulatory excellence. He has received multiple prestigious awards for his contributions to the field, including recognition from the FDA for his work on cell and gene therapies. His academic background includes a Ph.D. from MIT and a B.S. from Johns Hopkins University, underscoring his strong foundation in medical engineering and chemical engineering. Patrick's passion for research and development drives his innovative approach to solving complex challenges in the life sciences industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Patrick Au

Work Experience

company logo

Vice President, Translational Research and Early Development at

Ensoma

September 2021 - Present

company logo

Head of Nonclinical Development and Regulatory at

Ensoma

October 2019 - August 2021

company logo

Senior Director of Regulatory, Pharmacology and Toxicology at

Casebia Therapeutics

January 2019 - September 2019

company logo

Director of Regulatory, Pharmacology & Toxicology at

Casebia Therapeutics

September 2017 - December 2018

company logo

Pharmacology-Toxicology Lead at

Spark Therapeutics, Inc.

February 2016 - August 2017

company logo

Project Team Leader, Huntington's Disease at

Spark Therapeutics, Inc.

April 2016 - June 2017

company logo

Director of Regulatory Affairs at

Adverum Biotechnologies

October 2014 - December 2015

company logo

Pharmacology/Toxicology Reviewer at

FDA

July 2014 - September 2014

company logo

Acting Team Leader, Pharmacology/Toxicology at

FDA

December 2013 - May 2014

company logo

Pharmacology/Toxicology Reviewer at

FDA

June 2009 - November 2013

company logo

Research Fellow at

Massachusetts General Hospital

June 2008 - June 2009

company logo

Research Intern, Vaccine Bioproces Engineer at

Merck

June 2000 - September 2000

Logos provided by Logo.dev

Patrick Au

Education

Massachusetts Institute of Technology, Phd

January 2001 - January 2008

Harvard Medical School

January 2001 - January 2008

Johns Hopkins University, Bs

January 1997 - January 2001

Frequently Asked Questions about Patrick Au

What is Patrick Au email address?

Patrick Au's primary email address is ***@ensoma.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Patrick Au work for?

Patrick Au is a Vice President, Translational Research and Early Development at Ensoma, a company specializing in Commercial physical research.

Where Patrick Au graduated from?

Patrick Au holds a degree in Medical Engineering from Massachusetts Institute of Technology.

How can I directly contact Patrick Au?

To contact Patrick Au directly, you can use the email address ***@ensoma.com. Complete contact information is available upon registration with Muraena.

Who is Patrick Au?

Patrick Au is an accomplished Vice President specializing in Translational Research and Early Development within the biotechnology sector. With over 5 years of experience at the US FDA, he brings extensive knowledge in drug and biologics development across various therapeutic areas, including rare diseases and immuno-oncology. His expertise encompasses regulatory affairs, pharmacology, and toxicology, making him a key player in advancing innovative therapies. Patrick is a Diplomate of the American Board of Toxicology and holds a Regulatory Affairs Certification, highlighting his commitment to regulatory excellence. He has received multiple prestigious awards for his contributions to the field, including recognition from the FDA for his work on cell and gene therapies. His academic background includes a Ph.D. from MIT and a B.S. from Johns Hopkins University, underscoring his strong foundation in medical engineering and chemical engineering. Patrick's passion for research and development drives his innovative approach to solving complex challenges in the life sciences industry.

Patrick`s contact details

mail

***@ensoma.com

Colleagues

avatar
Paula Soteropoulos

Venture Partner

avatar
Stefano Stella

Vice President, Gene editing

avatar
Stephanie Fedak

Senior Vice President, People and Culture

avatar
Anthony Forget

Vice President, Platform Technologies

avatar
Betsy Bogard

Vice President, Program and Alliance Management

avatar
Daniel Leblanc

Chief Technology Officer

avatar
Elinor Shin

Senior Vice President, Legal and Intellectual Property

avatar
Chapman Wright

Vice President, Process and Analytical Development

avatar
John Desimone

Vice President Finance

View Contact details (it's free)
Request Profile Removal